-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Maintains Buy on Armata Pharmaceuticals, Raises Price Target to $9

Benzinga·05/19/2025 17:50:05
Listen to the news
HC Wainwright & Co. analyst Joseph Pantginis maintains Armata Pharmaceuticals (AMEX:ARMP) with a Buy and raises the price target from $7 to $9.